Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study

• Main Authors: Josephine G Walker, PhD (Author), Tinatin Kuchuloria, MD (Author), David Sergeenko, MD (Author), Hannah Fraser, PhD (Author), Aaron G Lim, DPhil (Author), Shaun Shadaker, MPH (Author), Liesl Hagan, MPH (Author), Amiran Gamkrelidze, ProfPhD (Author), Valeri Kvaratskhelia, MD (Author), Lia Gvinjilia, MD (Author), Malvina Aladashvili, MD (Author), Alexander Asatiani, MD (Author), Davit Baliashvili, MD (Author), Maia Butsashvili, ProfPhD (Author), Ivdity Chikovani, MD (Author), Irma Khonelidze, MD (Author), Irma Kirtadze, PhD (Author), Mark H Kuniholm, PhD (Author), David Otiashvili, PhD (Author), Lali Sharvadze, PhD (Author), Ketevan Stvilia, MD (Author), Tengiz Tsertsvadze, ProfPhD (Author), Mamuka Zakalashvili, MD (Author), Matthew Hickman, PhD (Author), Natasha K Martin, DPhil (Author), Juliette Morgan, MD (Author), Muazzam Nasrullah, PhD (Author), Francisco Averhoff, MD (Author), Peter Vickerman, ProfDPhil (Author)
• Format: Book
• Published: Elsevier, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Georgia has a high prevalence of hepatitis C, with 5·4% of adults chronically infected. On April 28, 2015, Georgia launched a national programme to eliminate hepatitis C by 2020 (90% reduction in prevalence) through scaled-up treatment and prevention interventions. We evaluated...